Details of the Drug Reposition

General Information of This Drug (ID: DMJA3H1)

Drug Name
Anti-CEA-CAR T   DMJA3H1
Drug Type
CAR T Cell Therapy

Information on Drug Reposition of This Drug

Molecular Interaction Atlas (MIA)
4 Phase 1 Indication(s)
Indication Name Indication ID ICD-11 Status REF
Gastric adenocarcinoma DISWWLTC 2B72 Phase 1 [1]
Colorectal cancer DISNH7P9 2B91.Z Phase 1 [1]
Pancreatic cancer DISJC981 2C10 Phase 1 [1]
Lung cancer DISCM4YA 2C25.0 Phase 1 [1]
------------------------------------------------------------------------------------

References

1 ClinicalTrials.gov (NCT02349724) A Clinical Research of CAR T Cells Targeting CEA Positive Cancer